Intercure(INCR) - 2023 Q4 - Annual Report
Intercure(INCR)2024-05-01 11:10Exhibit 99.1 InterCure Announces FY2023 Results: Revenue of NIS 356 million and Adjusted EBITDA of NIS 61 million NEW YORK & HERZLIYA, Israel, April 30, 2024- InterCure Ltd. (NASDAQ: INCR) (TASE: INCR) ("InterCure" or the "Company") today announced results for the full year ending December 31, 2023. All amounts are expressed in New Israeli Shekels (NIS), unless otherwise noted. FY2023 Financial Highlights and Milestones Adjusted EBITDA means EBITDA for the cannabis sector adjusted for changes in the fair va ...